Print
Health Care

Wilmington-based Pharmaceutical Firms Reveal Growth Steps

By Staff Reports, posted May 4, 2022
Alcami (pictured) and Catalyst Clinical Research are two Wilmington pharma firms with recent announcements. (File photo)
Two separate Wilmington-based pharmaceutical companies shared announcements this week. 

Catalyst Clinical Research, a provider of clinical research services, has acquired U.K.-based Aptus Clinical, achieving its goal of expanding in Europe, according to a press release Wednesday.

“Together, the two entities will become one multi-region clinical research organization with an accelerated growth trajectory in both the U.S. and Europe,” the release stated.

The company now has a combined 800 staff. The terms of the deal were not disclosed.

This acquisition gives Catalyst access to Aptus’ relationship with ECMC Network (Experimental Cancer Medicine Centre), a U.K. initiative for the discovery, development and testing of new cancer treatments.

“Positioned at the forefront of novel cancer treatment trends, Catalyst's active portfolio serves more than 5,300 cancer patients in need and will grow by nearly 600 patients concurrent to this acquisition,” the release stated.

“We are thrilled to be working with Aptus Clinical to expand our reach in the European market, serving clients around the globe to help develop innovative new therapies, improve patient outcomes and enhance our company's long-term impact," Catalyst Clinical Research CEO, Nick Dyer, said in the release.

Catalyst Clinical Research is a portfolio company of the global platform NovaQuest Capital Management LLC.

According to the release, Catalyst and Aptus will operate as Catalyst Oncology and will work on a portfolio of more than 100 active oncology studies through a network of 500 investigator sites. Additional studies outside oncology will be delivered under the Catalyst Flex solution.

This is Catalyst’s third acquisition and first international partnership. In 2019, the company purchased another Wilmington-based firm Triangle Biostatistics.

In addition, Wilmington-based Alcami announced this week it had partnered with Civica Inc., a nonprofit pharmaceutical firm that seeks to make generic medicines accessible and affordable.

With this partnership, Alacami will provide analytical support for products to be manufactured at Civica’s 140,000-square-foot sterile injectable manufacturing facility in Petersburg, Virginia.

"We are proud to support Civica and the important work they are doing to ensure the supply of high-quality generic medicines in the United States," Timothy Compton, chief business officer of Alcami, said in the release.

Among the services Alcami will provide include method establishment, validation, release and stability for inactive substances, drug substances and drug products, as well as formulation development support.

“Our partnership further strengthens our United States supply chain and supports our mission to make quality medicines accessible and affordable to everyone," Martin VanTrieste, president and CEO of Civica Rx, said in the release.
Ico insights

INSIGHTS

SPONSORS' CONTENT
Drewsmith copiersplus headshot

A Little More Communication, A Lot More Cohesion

Drew Smith - Copiers Plus
Jessiepowellheadshot webversion

5 Reasons to Build Custom Franchise Software

Jessie Powell - Wide Open Tech
Mikestonestreetcropped 862150530

How Natural Disasters Affect Community Associations: Insurance Policies & Filing Claims

Mike Stonestreet - CAMS (Community Association Management Services)

Trending News

Wilmington-based Firm Buys Carolina Beach Motel For $5M

Cece Nunn - Jun 24, 2022

Fit4Life Health Clubs To Open Two Gyms As Upgrades Continue

Johanna Cano - Jun 24, 2022

In The Current Issue

'Sauce Boss' Built Business From Scratch

It was the summer of 1989, and Sean O’Rourke had concocted his first iteration of what would eventually become the Surfer Slappin! barbecue...


Retooling A Workforce

North Carolina, like many other states, faces a severe shortage of manufacturing workers as companies bring their operations back to the Uni...


Developers Share Project Indigo Update

For Project Indigo, developers have been gathering input from the city of Southport as city officials head toward considering measures that...

Book On Business

The 2022 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

Trying to Grow a Business?
2020 Health Care Heroes
2020 WilmingtonBiz 100